In recent years, diabetes has reached epidemic proportions, affecting almost 14 million men, women, and children in Sub-Saharan Africa. It is one of the most heavily researched diseases of our time, yet it remains an incurable, progressive illness, with devastating complications such as blindness, neuropathy, and cardiovascular disorders. The past 10 years, however, have seen a revolution in diabetes care that will continue well into the 21st century. New pharmacological interventions, including new oral therapies and insulin formulations, noninvasive glucose monitors, and transplant procedures have recently become available or are just on the horizon, offering hope for sustainable treatment. With the advent of these therapeutic strategies, the East African Diabetes Study Group (EADSG) was launched in 2011 to provide educational programs and conduct research to further expand our knowledge of this debilitating illness and its treatment. EADSG will take action to reduce the devastating complications of diabetes mellitus. Its plan of action emphasizes treating diabetes to reach and maintain target levels of glucose, blood pressure, and lipids. EADSG is committed to excellence in education, research, and treatment of diabetes. EADSG welcomes to all endocrinologists, diabetologists, primary care physicians, diabetes educators, and other health care professionals who work with diabetes patients with a nominal Membership Fee of USD 50 annually.